Itafos (IFOS) Stock Price, News & Analysis

Company Overview

Itafos Inc. operates as a phosphate and specialty fertilizer company. It operates through Conda, Arrais, and Development and Exploration segments. The company produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, ammonium polyphosphate, hydrofluorosilicic acid, direct application phosphate rock, single superphosphate (SSP), SSP with micronutrients, and sulfuric acid. It also owns interests in the Farim, a phosphate mine project situated in Farim, Guinea-Bissau; Araxá, a rare earth element and niobium mine and extraction plant project that is situated in Minas Gerais, Brazil; Arraias, an integrated phosphate fertilizer project located in Tocantins, Brazil; and Santana, an integrated phosphate mine and fertilizer plant project located in Pará, Brazil. The company was formerly known as MBAC Fertilizer Corp. and changed its name to Itafos Inc. in December 2016. Itafos Inc. is headquartered in Houston, Texas.

Key Stats

• Today's Range: C$1.73 to C$1.79
• 50-Day Range: C$1.64 to C$2.51
• 52-Week Range: C$1.60 to C$4.67
• Volume: 36,151 shs
• Average Volume: 150,884 shs
• Market Capitalization: C$348.66 million
• P/E Ratio: 22.38
• Dividend Yield: 4.62%
• Price Target: C$3.75
• Consensus Rating: Buy

Itafos Stock Analysis - MarketRank™

Itafos scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

Itafos has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.

Upside Potential

Itafos has a consensus price target of C$3.75, representing about 116.8% upside from its current price of C$1.73.

Amount of Analyst Coverage

Itafos has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Itafos is 21.63, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.55.

Price to Earnings Ratio vs. Sector

The P/E ratio of Itafos is 21.63, which means that it is trading at a less expensive P/E ratio than the Materials sector average P/E ratio of about 28.99.

Price to Book Value per Share Ratio

Itafos has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for IFOS.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Itafos is a leading dividend payer. It pays a dividend yield of 4.62%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Itafos does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Itafos this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Itafos insiders have not sold or bought any company stock.

Percentage Held by Insiders

67.42% of the stock of Itafos is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

0.85% of the stock of Itafos is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Materials
• Industry: Chemicals
• Sub-Industry: N/A
• Current Symbol: CVE:IFOS
• CIK: N/A
• Web: itafos.com
• Phone: 713-239-2700
• Fax: N/A
• Employees: 470
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Itafos: C$3.75
• High Price Target: C$3.75
• Low Price Target: C$3.75
• Potential Upside/Downside: +116.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): C$0.08
• Trailing P/E Ratio: 21.63
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$6.85 million
• Net Margins: 3.07%
• Pretax Margin: N/A
• Return on Equity: 4.12%
• Return on Assets: 8.65%

Debt

• Debt-to-Equity Ratio: 30.59
• Current Ratio: 2.42
• Quick Ratio: 0.73

Sales & Book Value

• Annual Sales: C$589.83 million
• Price / Sales: 0.57
• Cash Flow: C$0.22 per share
• Price / Cash Flow: 7.77
• Book Value: C$2.24 per share
• Price / Book: 0.77

Miscellaneous

• Outstanding Shares: 194,780,000
• Free Float: N/A
• Market Cap: C$336.97 million
• Optionable: Not Optionable
• Beta: -0.18